Polynovo Limited (PNV:ASX)


right-arrow Created with Sketch. 0.17 (5.3%)
MCAP $2.234B
Last trade 16.10pm 01/12/2020 20mins delayed

Latest Announcements

16.42pm 01/12/2020PNVPolynovo Limited
16.42pm 01/12/2020PNVPolynovo Limited
09.14am 01/12/2020PNVPolynovo Limited
09.11am 01/12/2020PNVPolynovo Limited
19/11/2020 Price SensitivePSPNVPolynovo Limited
16/11/2020PNVPolynovo Limited
16/11/2020PNVPolynovo Limited
16/11/2020PNVPolynovo Limited

Company Overview

Polynovo Ltd is an Australia-based medical device company. The Company designs, develops and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. Its development program covers Breast Sling, Hernia and Orthopedic application. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture novel medical devices designed to support tissue repair and which then bio reabsorb in a defined fashion in-situ to harmless by-products. It manufactures NovoSorb polymer devices with the ability to elute drugs, antimicrobials as well as be expressed in a variety of physical formats, including films, foam, coatings/sprays, fibers, plastic structures and biological carrier. Its NovoSorb Biodegradable Temporising Matrix (BTM) is used in a fully debrided clean surgical wound to physiologically close the wound.

PNV in the news

Search Previous Announcements